Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction
Heat-clearing and Blood-activating Chinese Medicinal Components in Acute Cerebral Infarction: Mechanisms of Multi-target Anti-inflammatory Action
Sponsor: Huairou Hospital of Traditional Chinese Medicine
This NA trial investigates Ischemic Stroke and is currently ongoing. Huairou Hospital of Traditional Chinese Medicine leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Aug 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
May 2019 — Aug 2019 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Sep 2017 — Jun 2018 [monthly]
Recruiting NA
-
Jan 2017 — Sep 2017 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Huairou Hospital of Traditional Chinese Medicine
- Shandong University of Traditional Chinese Medicine
- Yunling Zhang
For direct contact, visit the study record on ClinicalTrials.gov .